GLP-1s are most well studied for weight loss (obesity) and blood sugar control (type 2 diabetes)
It should be noted that the inhibition of this pathway occurs in the early stage of the disease, so, it may be the important factor initiating and then sustaining the inflammatory-oxidative cascade
However, there are few studies in type 1 diabetes, so it is not clear whether this translates into increased rates of DKA." How certain side effects might impact insulin intake Anyone taking GLP-1s will likely experience a reduction in appetite, which is partly why they're so effective at weight reduction
6 International Foundation of Employee Benefit Plans.Pulse Survey: GLP-1 Drugs Corporate Only
For single dose pens like Mounjaro or Zepbound, some will attempt to extract partial doses by breaking open the device, bypassing its built in precision and safety mechanisms
and disappear as your body adjusts to the medicine